Health Affairs
What’s Next For Prescription Drug Affordability Boards After Amgen v. Mizner?Prescription Drug Affordability Boards
Issue Metadata
More Prescription Drug Affordability tracked topics
-
Price Gouging Laws
Cases Tracked: 7
-
Product Specific Access Laws
Cases Tracked: 5
-
Orange Book Patent Listings
Cases Tracked: 4
-
Transparency Laws
Cases Tracked: 2
Dive Deeper
O'Neill Institute
State Action to Lower Prescription Drug Prices: Navigating Patent PreemptionO'Neill Institute
Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription DrugsMore Issues
- 340B Program 21 cases
- Affordable Care Act 76 cases 6 Topics
- Anticompetitive Practices 26 cases 3 Topics
- Artificial Intelligence 3 cases
- Consumer Protections 17 cases 3 Topics
- Cost Containment 16 cases
- Equity 51 cases 1 Topics
- ERISA 18 cases
- Federal Health Funding 55 cases 5 Topics
- Medicare Advantage 37 cases 4 Topics
- Medicare Drug Price Negotiation 22 cases
- No Surprises Act 57 cases 4 Topics
- Reproductive Health 54 cases 5 Topics
- Site-Neutral Payments 9 cases
- Transparency 6 cases